Feedback PLC Appointment of new Medical Director
01 Juni 2018 - 8:00AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
01 June 2018
1 June 2018
Feedback plc
("Feedback" or the "Company")
Appointment of new Medical Director
Cambridge, UK - 1 June 2018: Feedback plc ("Feedback" or the
"Company") (AIM: FDBK), the specialist medical imaging technology
company, announces the appointment of Professor Rory Shaw as
Medical Director of Feedback's subsidiary company, Feedback Medical
Limited, effective immediately.
Professor Shaw is a highly experienced NHS executive with a
strong track record in strategy development and international
relations. In November 2013, he was appointed as Medical Director
of Healthcare UK, part of the Department of International Trade, to
lead the NHS International Development Team. In this role,
Professor Shaw was responsible for building relationships between
the NHS and foreign governments and healthcare providers in order
to leverage opportunities overseas. Prior to this, Professor Shaw
was a medical director in the NHS for over 15 years, latterly at
North West London Hospitals Trust, and previously at Royal
Berkshire Foundation Trust and Hammersmith Hospitals Trust. He has
also held national roles as non-executive of the NHS Litigation
Authority and previously as the first Chairman of the National
Patient Safety Agency. Professor Shaw is a consultant respiratory
physician and is a named author on over 140 scientific
publications.
David Crabb, Chief Executive Officer of Feedback plc, said:
"With a unique combination of clinical and international engagement
experience, Professor Shaw brings a highly complementary skill-set
to the team. His clinical input, together with Dr Balaji Ganeshan's
market expertise, will underpin our product development strategy
following the first CE marked release of the TexRAD(R) technology.
Furthermore, Professor Shaw's international reach will be
invaluable as we continue to pursue opportunities to increase
TexRAD and Cadran platform technology sales globally."
Professor Rory Shaw, Medical Director of Feedback Medical
Limited, commented: "The TexRAD technology provides a way of
obtaining a new level of information about cancers by using
Artificial Intelligence to undertake an in-depth analysis of CT
scans and other images. The next exciting phase is to understand
how this new information can be used in the clinical care of
patients with diseases such as lung cancer, to enable better
disease staging and thus to enable more effective cancer
treatment."
Professor Shaw will also be appointed as a Director of Feedback
Medical Limited.
- Ends -
Notes to editors
About Feedback plc
Feedback plc is a specialist medical imaging technology company.
It develops software and systems that provide innovative techniques
and improved workflows for practitioners involved in medical
research and treating patients. TexRAD(R) , the Company's patented
quantitative image texture analysis technology, has the potential
to assist clinicians in diagnosis, prognosis and treatment of
patients with cancer and is currently installed in over 40 of the
world's leading research institutions across Europe, North America,
Asia and Australasia. The Cadran platform provides a suite of
medical imaging tools for decision support. The Cadran range
includes the picture archiving communication system (PACS) to
provide decision support for scan analysis, diagnostic workstations
which provide secure remote access to view scans on demand, and
products to securely share and transport patient data. Visit
www.fbk.com.
For further information, please contact:
Feedback plc
David Crabb, Chief Executive Officer Tel: 01954 718072
Lara Mott, Investor Relations IR@fbk.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAZMGFKFMRGRZM
(END) Dow Jones Newswires
June 01, 2018 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024